HDFC PHARMA AND HEALTHCARE FUND REGULAR IDCW REINVESTMENT - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Status: Open
Portfolio Overview
As of March 31, 2026
Asset Allocation
Equity: 98.51%Others: 1.49%
Market Cap
Large Cap: 20.74%Mid Cap: 34.03%Small Cap: 33.31%Others: 10.43%
Number of stocks
30
Top 10 Holdings
63.31% of portfolio
Market Cap of Equity
Large Cap
20.74%
Mid Cap
34.03%
Small Cap
33.31%
Others
10.43%
Companies Allocation of Equity
Sun Pharmaceuticals Industries Ltd10.20%
Divi's Laboratories Ltd8.20%
Glenmark Pharmaceuticals Ltd6.78%
Lupin Ltd6.65%
Alkem Laboratories Ltd5.99%
Max Healthcare Institute Ltd Ordinary Shares5.96%
Aster DM Healthcare Ltd Ordinary Shares5.70%
Ipca Laboratories Ltd5.16%
Acutaas Chemicals Ltd4.39%
Anthem Biosciences Ltd4.29%
Sector Allocation of Equity
Healthcare94.12%
Basic Materials4.39%
SIP Amount
Monthly SIP Date
HDFC PHARMA AND HEALTHCARE FUND REGULAR IDCW REINVESTMENT


Is This Mutual Fund Right for You?
+10k investors used our Suitability Test to get better returns
Fund Suitability Test
Let's Get Started.
Frequently Asked Questions
Everything You Need To Know To Get Started With Confidence
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.